New perspectives on metabolic imaging in the management of prostate cancer in 2022: A focus on radiolabeled PSMA‑PET/CT (Review)

Nuclear medicine is an essential part of prostate cancer management concerning initial staging, patient follow-up and even therapy. Prostate-specific membrane antigen (PSMA) is a glutamate carboxypeptidase II transmembrane glycoprotein expressed by 80% of prostatic cells. The interest in this protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Hélène, Henkel, Daniel, Chiron, Paul, Helissey, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265585/
https://www.ncbi.nlm.nih.gov/pubmed/37323248
http://dx.doi.org/10.3892/mco.2023.2647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265585/
https://www.ncbi.nlm.nih.gov/pubmed/37323248
http://dx.doi.org/10.3892/mco.2023.2647

Ejemplares similares